Search

everythinglearnresearchcommunity

for

Search:↓

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The document emphasizes the need for primary care providers to understand and care for African American children's hair and skin to boost their self-esteem.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Artificial hair implantation using scaffolds is possible and PHDPE is more biocompatible than ePTFE.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

New understanding and treatments for hair loss are improving, but more research is needed.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

The herbal hair serum improves hair quality and growth, and is a good alternative to traditional cosmetics because it doesn't contain harmful chemicals like parabens and sulphates.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.